Emergency Room Analgesia and Sedation Survey-2

NCT ID: NCT07152457

Last Updated: 2025-09-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

13000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-09-01

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Part 1: Assessment of Healthcare Providers' Knowledge on Analgesia and Sedation in Emergency Resuscitation Rooms Across China This study aims to evaluate the understanding of healthcare providers in emergency resuscitation rooms regarding the principles of analgesia and sedation, commonly used assessment tools, and delirium management, and to identify key factors that may influence their level of knowledge. Part 2: Implementation Practices of Analgesia and Sedation in Emergency Resuscitation Rooms Across China: A Multicenter Prospective Cohort Study Primary Objective: To assess the extent of adherence to standardized protocols for analgesia and sedation in emergency resuscitation rooms of general hospitals in China. Secondary Objectives: (1) To identify key factors affecting compliance with standardized analgesia and sedation practices in emergency resuscitation settings, thereby providing evidence for targeted interventions; (2) To examine the impact of analgesia and sedation implementation on clinical outcomes and prognosis of patients in emergency resuscitation rooms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Current Status of Analgesia and Sedation Cognition and Implementation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

None intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. : Part 1: (1) Healthcare professionals currently assigned to the emergency department and actively working in the emergency resuscitation room; (2) With at least one year of clinical experience in emergency medicine; (3) Willing to voluntarily participate in the investigation. Each participating institution is required to enroll a minimum of 12 healthcare providers, including at least 6 physicians and 6 nurses. Within each group (physicians and nurses), at least 3 participants must hold junior professional titles and at least 3 must hold intermediate or senior-level professional titles.
2. Part 2: All adult patients (≥18 years of age) admitted to the emergency resuscitation room during the period from July 15, 2025 to July 30, 2025.

Exclusion Criteria

1. Pregnant women
2. patients undergoing end-of-life care
3. individuals incapable of providing informed consent
4. patients who decline participation.
Minimum Eligible Age

18 Years

Maximum Eligible Age

120 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Zhongjun Zheng

Role: CONTACT

+8615869119921

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

No funding is currently availa

Identifier Type: OTHER

Identifier Source: secondary_id

2025-0530

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.